📰 Rns Pharma News
Rns Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rns Pharma. Real-time updates on events, politics, business and more.
December 21, 2023
/PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced that, on December 13, 2023, the European Commission (EC) has...
November 21, 2023
/PRNewswire/ -- NS Pharma, Inc. ("NS Pharma") today announced the launch of Duchenne Heroes a program created to raise awareness and champion the voices of...
October 17, 2023
/PRNewswire/ -- NS Pharma, Inc. announced today the publication of preclinical data on NS-089/NCNP-02 (brogidirsen), an investigational candidate for patients...
August 14, 2023
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today reported its financial results for the quarter ended June 30, 2023, provided a corporate update and reiterates upcoming milestones.
July 7, 2023
/PRNewswire/ -- NS Pharma, Inc. announced today the U.S. Food & Drug Administration (FDA) has granted Rare Pediatric Disease Designation to NS-089/NCNP-02...
April 14, 2023
/PRNewswire/ -- NS Pharma, Inc. announced today the U.S. Food & Drug Administration (FDA) has agreed to the planned Phase II study of NS-089/NCNP-02 for...
March 19, 2023
/PRNewswire/ -- NS Pharma is pleased to announce participation in the Muscular Dystrophy Associations (MDA) Clinical & Scientific Congress 2023 being held in...
February 17, 2023
/PRNewswire/ -- NS Pharma, Inc. announced today the first patient enrollment in a Phase 2 clinical study of NS-018 (ilginatinib), an investigational treatment...
January 6, 2023
/PRNewswire/ -- NS Pharma announced today the opening of a new office in Cambridge, Massachusetts, to establish the NS Pharma Innovation Research Partnering...
December 20, 2022
/PRNewswire/ -- NS Pharma, Inc. (NS Pharma; President, Tsugio Tanaka), a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku; President, Toru...